Ellington Management Group’s Pacific Biosciences PACB Stock Holding History

Ellington Management Group’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-31,100	Closed	-$264K	–	430
2016 Q1	$264K	Buy	+31,100	New	+$306K	0.11%	267
2015 Q3	–	Sell	-25,695	Closed	-$148K	–	844
2015 Q2	$148K	Buy	+25,695	New	+$149K	0.04%	628
2015 Q1	–	Sell	-10,000	Closed	-$78K	–	782
2014 Q4	$78K	Sell	10,000 -12,800	-56%	-$81.9K	0.03%	536
2014 Q3	$112K	Sell	22,800 -5,300	-19%	-$27.7K	0.08%	264
2014 Q2	$174K	Sell	28,100 -11,200	-28%	-$56.1K	0.08%	375
2014 Q1	$210K	Sell	39,300 -49,400	-56%	-$312K	0.06%	514
2013 Q4	$464K	Buy	+88,700	New	+$407K	0.17%	198

Other funds holding PACB

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Ellington Management Group's PACB Position: Q2 2016 in Review

Ellington Management Group sold out of Pacific Biosciences (PACB) in Q2 2016, closing a stake of 31,100 shares — an estimated $264K sold.

Ellington Management Group first reported a position in PACB in Q4 2013 and held it in 7 quarters. The position peaked at $464K in Q4 2013. 141 funds tracked by Wall St. Rank hold PACB as of Q2 2016.

Ellington Management Group reported no remaining Pacific Biosciences position as of Q2 2016 after selling out during the quarter.
Ellington Management Group sold 31,100 Pacific Biosciences shares in Q2 2016, an estimated $264K.
Ellington Management Group first reported a position in Pacific Biosciences in Q4 2013 and held it in 7 quarters.
Ellington Management Group's Pacific Biosciences position peaked at $464K in Q4 2013.
141 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2016.

Based on Ellington Management Group's 13F filing for Q2 2016, filed 15 Aug 2016.